ESR1 and breast cancer: In this study, we compared both BCSS and OS between ER-positive/PR-positive, ER-positive/PR-negative, ER-negative/PR-positive, and ER-negative/PR-negative breast cancers with bone metastases, indicating that metastasis to the same organ confers different rates of survival depending on the HR status of breast cancer.